PER 2.86% 7.2¢ percheron therapeutics limited

Ann: Phase II DMD trial database lock and final results on track, page-95

  1. 2,963 Posts.
    lightbulb Created with Sketch. 489
    Still a couple of weeks to go! -

    Quarterly Update & Appendix 4C • DMD Phase II trial final results due in the coming weeks • US-based Consultant Medical Director appointed to accelerate development activities • Positive results in DMD unlock the broader value creation potential of ATL1102
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $64.91M
Open High Low Value Volume
7.4¢ 7.4¢ 7.0¢ $44.32K 616.8K

Buyers (Bids)

No. Vol. Price($)
1 4250 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 49809 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.